ACUTE EXUDATIVE MACULOPATHY AND BACILLARY LAYER DETACHMENT IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY AFTER PHOTODYNAMIC THERAPY
- 10 January 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 42 (5) , 859-866
Abstract
Purpose: To describe the incidence and characteristics of photodynamic therapy–induced acute exudative maculopathy (PAEM) and bacillary layer detachment in patients with chronic central serous chorioretinopathy. Methods: This was a prospective observational case series including 92 eyes of 75 patients who underwent photodynamic therapy. Best-corrected visual acuity, optical coherence tomography, and optical coherence tomography angiography were performed before, 3 days, 1 month, and 3 months after half-fluence photodynamic therapy. Two groups were established depending on the presence or absence (N = 28 and N = 64, respectively) of PAEM. Choriocapillaris flow voids increase, subfoveal choroidal thickness, and the presence of choroidal neovascularization were collected. Results: The incidence of PAEM was 28/92 (30.4%). There was no difference in the age, sex, baseline subretinal fluid, subfoveal choroidal thickness, or the presence of choroidal neovascularization between groups (P ≥ 0.094). No differences emerged in the subretinal fluid at 1 and 3 months after photodynamic therapy between groups (P ≥ 0.524), nor in the mean best-corrected visual acuity gain at 3 months (4.1 ± 7.6 vs. 3.6 ± 6.4 letters; P = 0.773). A bacillary layer detachment was observed in 13 patients with PAEM (46.4%). Conclusion: Photodynamic therapy–induced acute exudative maculopathy is frequent in patients with chronic central serous chorioretinopathy but has a favorable prognosis. There was no association between PAEM and age, sex, subfoveal choroidal thickness, or choroidal neovascularization; however, it was related to choriocapillaris flow voids increase.Keywords
This publication has 24 references indexed in Scilit:
- Response to “Exudative complications following photodynamic therapy”Canadian Journal of Ophthalmology, 2017
- Exudative complications following photodynamic therapyCanadian Journal of Ophthalmology, 2017
- Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case reportCanadian Journal of Ophthalmology, 2017
- INCIDENCE OF ACUTE EXUDATIVE MACULOPATHY AFTER REDUCED-FLUENCE PHOTODYNAMIC THERAPYRETINAL Cases & Brief Reports, 2017
- Central serous chorioretinopathy: Recent findings and new physiopathology hypothesisProgress in Retinal and Eye Research, 2015
- Transient increased exudation after photodynamic therapy of intraocular tumorsMiddle East African Journal of Ophthalmology, 2013
- Influence of Treatment Parameters on Selectivity of Verteporfin TherapyInvestigative Ophthalmology & Visual Science, 2006
- Complications After Photodynamic TherapyArchives of Ophthalmology (1950), 2005
- Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease levelBritish Journal of Ophthalmology, 2003
- Fibrin Directs Early Retinal Damage After Experimental Subretinal HemorrhageArchives of Ophthalmology (1950), 1991